Related Experiment Video

Updated: Sep 3, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract

F Baquero1, R Cantón

  • 1Department of Microbiology, Ramón y Cajal Hospital, National Institute of Health (INSALUD), Madrid, Spain.

The Journal of Antimicrobial Chemotherapy
|May 1, 1996
PubMed

Insights

Sparfloxacin shows effectiveness against drug-resistant bacteria causing respiratory infections. This fluoroquinolone may be a good option for treating community-acquired respiratory tract infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial resistance is a growing global health concern.
  • Respiratory tract infections pose a significant public health challenge.
  • Novel therapeutic strategies are needed to combat resistant bacterial pathogens.

Purpose of the Study:

  • To review the in vitro activity of sparfloxacin against respiratory tract pathogens.
  • To compare sparfloxacin's efficacy with existing antimicrobial agents.
  • To evaluate sparfloxacin as a potential empirical therapy for community-acquired respiratory tract infections.

Main Methods:

  • Literature review of in vitro studies.
  • Analysis of antimicrobial susceptibility data.
  • Comparison of sparfloxacin with standard antibiotics.

Main Results:

  • Sparfloxacin demonstrates potent in vitro activity against Streptococcus pneumoniae, including penicillin-resistant strains.
  • The drug is effective against a range of other common respiratory pathogens.
  • Sparfloxacin exhibits broad-spectrum activity relevant to respiratory infections.

Conclusions:

  • Sparfloxacin is active against key pathogens in respiratory tract infections.
  • Its efficacy against resistant Streptococcus pneumoniae strains is noteworthy.
  • Sparfloxacin presents a potential alternative for empirical treatment of community-acquired respiratory tract infections.

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...